Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH
CAS No. 120173-57-1
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH ( Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH;Fmoc-Ser[GalNAc(Ac)3-α-D]-OH;Fmoc-Ser(Ac3AcNH-α-Gal)-OH )
Catalog No. M20913 CAS No. 120173-57-1
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is an anti-tumor drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 39 | Get Quote |
|
5MG | 61 | Get Quote |
|
10MG | 87 | Get Quote |
|
25MG | 160 | Get Quote |
|
50MG | 259 | Get Quote |
|
100MG | 419 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFmoc-Ser(O-α-D-GalNAc(OAc)3)-OH
-
NoteResearch use only not for human use.
-
Brief DescriptionFmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is an anti-tumor drug.
-
DescriptionFmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is an anti-tumor drug.
-
SynonymsFmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH;Fmoc-Ser[GalNAc(Ac)3-α-D]-OH;Fmoc-Ser(Ac3AcNH-α-Gal)-OH
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number120173-57-1
-
Formula Weight656.63
-
Molecular FormulaC32H36N2O13
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (152.29 mM)
-
SMILESCC(=O)N[C@H]1[C@@H](OC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eberling J Braun P Kowalczyk D et al. ChemInform Abstract: Chemoselective Removal of Protecting Groups from O‐Glycosyl Amino Acid and Peptide (Methoxyethoxy)ethyl Esters Using Lipases and Papain.[J]. ChemInform 1996 27.
molnova catalog
related products
-
Echimidine
Echimidine, a major hepatotoxic dehydropyrrolizidine alkaloid produced by E. plantagineum, in the honey (780 ng/g) and in the subsequent mead samples (236-540 ng/mL). Echimidine-N-Oxide has antifungal activity.
-
(-)-α-Pinene
(1S)-(-)-Alpha-Pinene enhances the quantity of NREMS without affecting the intensity of NREMS by prolonging GABAergic synaptic transmission, acting as a partial modulator of GABAA-BZD receptors and directly binding to the BZD binding site of GABAA receptor.
-
Lauroyl glutamic aci...
Lauroyl glutamic acid exhibits antiasthmatic effects.